CSIR suggests cap on remdesivir price

The Council of Scientific and Industrial Research (CSIR) has suggested regulating price of the experimental Covid-19 medicine remdesivir used in hospitalised patients who are on oxygen support on the basis of a cost analysis of the API used in the formulation.

source https://timesofindia.indiatimes.com/india/csir-suggests-cap-on-remdesivir-price/articleshow/77009836.cms

Comments